In fact, a phase 2B clinical trial revealed that itch in psoriasis patients could be successfully alleviated by NTRK1 inhibition28, furthering a causal link between upregulated NGF-NTRK1 interaction in the skin and chronic itch. Here, NGF is linked to psoriasis.